119 related articles for article (PubMed ID: 17867665)
1. 1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.
Micheli F; Bonanomi G; Blaney FE; Braggio S; Capelli AM; Checchia A; Curcuruto O; Damiani F; Fabio RD; Donati D; Gentile G; Gribble A; Hamprecht D; Tedesco G; Terreni S; Tarsi L; Lightfoot A; Stemp G; Macdonald G; Smith A; Pecoraro M; Petrone M; Perini O; Piner J; Rossi T; Worby A; Pilla M; Valerio E; Griffante C; Mugnaini M; Wood M; Scott C; Andreoli M; Lacroix L; Schwarz A; Gozzi A; Bifone A; Ashby CR; Hagan JJ; Heidbreder C
J Med Chem; 2007 Oct; 50(21):5076-89. PubMed ID: 17867665
[TBL] [Abstract][Full Text] [Related]
2. New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.
Micheli F; Bonanomi G; Braggio S; Capelli AM; Celestini P; Damiani F; Di Fabio R; Donati D; Gagliardi S; Gentile G; Hamprecht D; Petrone M; Radaelli S; Tedesco G; Terreni S; Worby A; Heidbreder C
Bioorg Med Chem Lett; 2008 Feb; 18(3):901-7. PubMed ID: 18248991
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of trans-3-(2-(4-((3-(3-(5-methyl-1,2,4-oxadiazolyl))- phenyl)carboxamido)cyclohexyl)ethyl)-7-methylsulfonyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SB-414796): a potent and selective dopamine D3 receptor antagonist.
Macdonald GJ; Branch CL; Hadley MS; Johnson CN; Nash DJ; Smith AB; Stemp G; Thewlis KM; Vong AK; Austin NE; Jeffrey P; Winborn KY; Boyfield I; Hagan JJ; Middlemiss DN; Reavill C; Riley GJ; Watson JM; Wood M; Parker SG; Ashby CR
J Med Chem; 2003 Nov; 46(23):4952-64. PubMed ID: 14584946
[TBL] [Abstract][Full Text] [Related]
4. 1,2,4-Triazolyl azabicyclo[3.1.0]hexanes: a new series of potent and selective dopamine D(3) receptor antagonists.
Micheli F; Arista L; Bonanomi G; Blaney FE; Braggio S; Capelli AM; Checchia A; Damiani F; Di-Fabio R; Fontana S; Gentile G; Griffante C; Hamprecht D; Marchioro C; Mugnaini M; Piner J; Ratti E; Tedesco G; Tarsi L; Terreni S; Worby A; Ashby CR; Heidbreder C
J Med Chem; 2010 Jan; 53(1):374-91. PubMed ID: 19891474
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors.
Campiani G; Butini S; Trotta F; Fattorusso C; Catalanotti B; Aiello F; Gemma S; Nacci V; Novellino E; Stark JA; Cagnotto A; Fumagalli E; Carnovali F; Cervo L; Mennini T
J Med Chem; 2003 Aug; 46(18):3822-39. PubMed ID: 12930145
[TBL] [Abstract][Full Text] [Related]
6. Exploration of the amine terminus in a novel series of 1,2,4-triazolo-3-yl-azabicyclo[3.1.0]hexanes as selective dopamine D3 receptor antagonists.
Micheli F; Arista L; Bertani B; Braggio S; Capelli AM; Cremonesi S; Di-Fabio R; Gelardi G; Gentile G; Marchioro C; Pasquarello A; Provera S; Tedesco G; Tarsi L; Terreni S; Worby A; Heidbreder C
J Med Chem; 2010 Oct; 53(19):7129-39. PubMed ID: 20839775
[TBL] [Abstract][Full Text] [Related]
7. 1,2,4-Triazolyl octahydropyrrolo[2,3-b]pyrroles: A new series of potent and selective dopamine D3 receptor antagonists.
Micheli F; Bernardelli A; Bianchi F; Braggio S; Castelletti L; Cavallini P; Cavanni P; Cremonesi S; Dal Cin M; Feriani A; Oliosi B; Semeraro T; Tarsi L; Tomelleri S; Wong A; Visentini F; Zonzini L; Heidbreder C
Bioorg Med Chem; 2016 Apr; 24(8):1619-36. PubMed ID: 26951894
[TBL] [Abstract][Full Text] [Related]
8. 4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.
Procopiou PA; Ancliff RA; Bamford MJ; Browning C; Connor H; Davies S; Fogden YC; Hodgson ST; Holmes DS; Looker BE; Morriss KM; Parr CA; Pickup EA; Sehmi SS; White GV; Watts CJ; Wilson DM; Woodrow MD
J Med Chem; 2007 Dec; 50(26):6706-17. PubMed ID: 18052318
[TBL] [Abstract][Full Text] [Related]
9. Effects of RGH-237 [N-{4-[4-(3-aminocarbonyl-phenyl)-piperazin-1-yl]-butyl}-4-bromo-benzamide], an orally active, selective dopamine D(3) receptor partial agonist in animal models of cocaine abuse.
Gyertyán I; Kiss B; Gál K; Laszlovszky I; Horváth A; Gémesi LI; Sághy K; Pásztor G; Zájer M; Kapás M; Csongor EA; Domány G; Tihanyi K; Szombathelyi Z
J Pharmacol Exp Ther; 2007 Mar; 320(3):1268-78. PubMed ID: 17170312
[TBL] [Abstract][Full Text] [Related]
10. 2-(Pyrrolidin-1-yl)ethyl-3,4-dihydroisoquinolin-1(2H)-one derivatives as potent and selective histamine-3 receptor antagonists.
Zhou D; Gross JL; Adedoyin AB; Aschmies SB; Brennan J; Bowlby M; Di L; Kubek K; Platt BJ; Wang Z; Zhang G; Brandon N; Comery TA; Robichaud AJ
J Med Chem; 2012 Mar; 55(5):2452-68. PubMed ID: 22313242
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of novel tricyclic benzoxazines as potent 5-HT(1A/B/D) receptor antagonists leading to the discovery of 6-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}-4H-imidazo[5,1-c][1,4]benzoxazine-3-carboxamide (GSK588045).
Bromidge SM; Arban R; Bertani B; Bison S; Borriello M; Cavanni P; Dal Forno G; Di-Fabio R; Donati D; Fontana S; Gianotti M; Gordon LJ; Granci E; Leslie CP; Moccia L; Pasquarello A; Sartori I; Sava A; Watson JM; Worby A; Zonzini L; Zucchelli V
J Med Chem; 2010 Aug; 53(15):5827-43. PubMed ID: 20590088
[TBL] [Abstract][Full Text] [Related]
12. 1,2,4-Triazolyl 5-Azaspiro[2.4]heptanes: Lead Identification and Early Lead Optimization of a New Series of Potent and Selective Dopamine D3 Receptor Antagonists.
Micheli F; Bacchi A; Braggio S; Castelletti L; Cavallini P; Cavanni P; Cremonesi S; Dal Cin M; Feriani A; Gehanne S; Kajbaf M; Marchió L; Nola S; Oliosi B; Pellacani A; Perdonà E; Sava A; Semeraro T; Tarsi L; Tomelleri S; Wong A; Visentini F; Zonzini L; Heidbreder C
J Med Chem; 2016 Sep; 59(18):8549-76. PubMed ID: 27564135
[TBL] [Abstract][Full Text] [Related]
13. Effects of the selective dopamine D3 receptor antagonist SB-277011A on the reinforcing effects of nicotine as measured by a progressive-ratio schedule in rats.
Ross JT; Corrigall WA; Heidbreder CA; LeSage MG
Eur J Pharmacol; 2007 Mar; 559(2-3):173-9. PubMed ID: 17303116
[TBL] [Abstract][Full Text] [Related]
14. Cariprazine (RGH-188), a dopamine D(3) receptor-preferring, D(3)/D(2) dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile.
Kiss B; Horváth A; Némethy Z; Schmidt E; Laszlovszky I; Bugovics G; Fazekas K; Hornok K; Orosz S; Gyertyán I; Agai-Csongor E; Domány G; Tihanyi K; Adham N; Szombathelyi Z
J Pharmacol Exp Ther; 2010 Apr; 333(1):328-40. PubMed ID: 20093397
[TBL] [Abstract][Full Text] [Related]
15. Selective antagonism at dopamine D3 receptors attenuates cocaine-seeking behaviour in the rat.
Cervo L; Cocco A; Petrella C; Heidbreder CA
Int J Neuropsychopharmacol; 2007 Apr; 10(2):167-81. PubMed ID: 16426478
[TBL] [Abstract][Full Text] [Related]
16. Effect of a D3 receptor antagonist on context-induced reinstatement of nicotine seeking.
Sabioni P; Di Ciano P; Le Foll B
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():149-54. PubMed ID: 26279138
[TBL] [Abstract][Full Text] [Related]
17. New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.
Micheli F; Bonanomi G; Braggio S; Capelli AM; Damiani F; Di Fabio R; Donati D; Gentile G; Hamprecht D; Perini O; Petrone M; Tedesco G; Terreni S; Worby A; Heidbreder C
Bioorg Med Chem Lett; 2008 Feb; 18(3):908-12. PubMed ID: 18178090
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and SAR of highly potent and selective dopamine D3-receptor antagonists: variations on the 1H-pyrimidin-2-one theme.
Geneste H; Amberg W; Backfisch G; Beyerbach A; Braje WM; Delzer J; Haupt A; Hutchins CW; King LL; Sauer DR; Unger L; Wernet W
Bioorg Med Chem Lett; 2006 Apr; 16(7):1934-7. PubMed ID: 16439127
[TBL] [Abstract][Full Text] [Related]
19. Evidence for the role of dopamine D3 receptors in oral operant alcohol self-administration and reinstatement of alcohol-seeking behavior in mice.
Heidbreder CA; Andreoli M; Marcon C; Hutcheson DM; Gardner EL; Ashby CR
Addict Biol; 2007 Mar; 12(1):35-50. PubMed ID: 17407496
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and structure-activity relationships of novel histamine H1 antagonists: indolylpiperidinyl benzoic acid derivatives.
Fonquerna S; Miralpeix M; Pagès L; Puig C; Cardús A; Antón F; Cárdenas A; Vilella D; Aparici M; Calaf E; Prieto J; Gras J; Huerta JM; Warrellow G; Beleta J; Ryder H
J Med Chem; 2004 Dec; 47(25):6326-37. PubMed ID: 15566302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
